Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea
2016; Elsevier BV; Volume: 129; Issue: 5 Linguagem: Inglês
10.1182/blood-2016-09-737817
ISSN1528-0020
AutoresChi A., Liqiang Xi, Brian Cauff, Adam DeZure, Alexandra F. Freeman, Sophie Hambleton, Gary Kleiner, Timothy Ronan Leahy, Maureen J. O’Sullivan, Michelle Makiya, Gráinne M. O’Regan, Stefania Pittaluga, Julie E. Niemela, Jennifer Stoddard, Sergio D. Rosenzweig, Mark Raffeld, Amy D. Klion, Joshua D. Milner,
Tópico(s)Eosinophilic Disorders and Syndromes
ResumoTo the editor: Somatic, gain-of-function mutations in STAT3 and STAT5 have been described in leukemias and lymphomas[1][1][⇓][2][⇓][3][⇓][4][⇓][5]-[6][6] and, more recently, in CD3-CD4+ T cells from a patient with lymphocytic variant hypereosinophilic syndrome[7][7]; whereas germ line gain-
Referência(s)